Colgate-Palmolive vs Ambev
Colgate-Palmolive vs Ambev is a page that compares business models, financial performance, and market context between the two companies. It presents neutral information on how each operates and the environments in which they compete. The aim is to inform readers with clear, accessible language, not to advocate any view. Educational content, not financial advice.
Colgate-Palmolive vs Ambev is a page that compares business models, financial performance, and market context between the two companies. It presents neutral information on how each operates and the en...
Why It's Moving
Analysts Pile On with Higher Price Targets for Colgate-Palmolive After Q4 Earnings Beat
- TD Cowen hiked its target to $96 from $86, citing Q4 earnings strength, 2026 EPS outlook at $3.87 with 5% growth, and gains in Latin America, India, and China.
- JP Morgan lifted target to $97 from $93 on February 2, maintaining Overweight amid sequential EPS improvement and above-peer earnings visibility.
- Bank of America boosted target to $100 with a Buy rating, while Q4 revenue surged 5.8% year-over-year, underscoring resilience in consumer staples demand.
Ambev Faces Analyst Downgrade Pressure Amid Steady Trading Near 52-Week Highs
- Analysts issued a 'Reduce' rating with seven Holds and one Sell, signaling limited upside potential and weighing on investor sentiment.
- Stock opened at $2.78 with a $43.8B market cap and P/E of 15.45, trading above 50-day ($2.55) and 200-day ($2.38) moving averages.
- Recent special dividend of $0.049 per share paid in January bolsters yield appeal, even as Q3 revenue slightly missed estimates at $3.90B versus $3.97B expected.
Analysts Pile On with Higher Price Targets for Colgate-Palmolive After Q4 Earnings Beat
- TD Cowen hiked its target to $96 from $86, citing Q4 earnings strength, 2026 EPS outlook at $3.87 with 5% growth, and gains in Latin America, India, and China.
- JP Morgan lifted target to $97 from $93 on February 2, maintaining Overweight amid sequential EPS improvement and above-peer earnings visibility.
- Bank of America boosted target to $100 with a Buy rating, while Q4 revenue surged 5.8% year-over-year, underscoring resilience in consumer staples demand.
Ambev Faces Analyst Downgrade Pressure Amid Steady Trading Near 52-Week Highs
- Analysts issued a 'Reduce' rating with seven Holds and one Sell, signaling limited upside potential and weighing on investor sentiment.
- Stock opened at $2.78 with a $43.8B market cap and P/E of 15.45, trading above 50-day ($2.55) and 200-day ($2.38) moving averages.
- Recent special dividend of $0.049 per share paid in January bolsters yield appeal, even as Q3 revenue slightly missed estimates at $3.90B versus $3.97B expected.
Investment Analysis
Pros
- Colgate-Palmolive reported revenue growth of 3.31% in 2024, reaching $20.10 billion, indicating steady top-line expansion.
- The company has strong brand diversification across oral care, personal care, home care, and pet nutrition segments, supporting market resilience.
- Colgate-Palmolive maintains a solid dividend yield around 2.7%, offering a consistent income stream for shareholders.
Considerations
- Colgate-Palmolive's stock has shown limited price appreciation over the past year, which may be unattractive for growth-focused investors.
- The company has a relatively high debt-to-equity ratio, which raises concerns about its financial leverage and risk exposure.
- Its price-to-earnings (P/E) ratio near 22 suggests potential overvaluation compared to peers, limiting upside from current levels.
Ambev
ABEV
Pros
- Ambev is a leading beverage company in Latin America with strong market share in beer and soft drinks, benefiting from regional brand loyalty and scale.
- The company has demonstrated growth potential driven by premium product launches and expansion in emerging markets with rising consumer incomes.
- Ambev maintains efficient production and distribution infrastructure, supporting operational margins despite commodity price volatility.
Considerations
- Ambev faces currency volatility risks due to significant exposure to emerging markets with fluctuating exchange rates impacting earnings.
- The company's performance is sensitive to regulation and taxation changes in the alcoholic beverages sector, which can constrain profitability.
- Economic slowdown or reduced consumer spending in key Latin American markets poses demand risks given Ambev's market concentration.
Related Market Insights
Why Familiar Brands Could Be Your Gateway to Stock Market Success
Nervous about investing? Discover how familiar consumer brands like Coca-Cola, PepsiCo & Ambev offer stability, dividends, and an accessible entry point to the stock market. Start with Nemo from £1.
Aimee Silverwood | Financial Analyst
October 13, 2025
Related Market Insights
Why Familiar Brands Could Be Your Gateway to Stock Market Success
Nervous about investing? Discover how familiar consumer brands like Coca-Cola, PepsiCo & Ambev offer stability, dividends, and an accessible entry point to the stock market. Start with Nemo from £1.
Aimee Silverwood | Financial Analyst
October 13, 2025
Colgate-Palmolive (CL) Next Earnings Date
Colgate-Palmolive's next earnings report is scheduled for April 23-24, 2026, covering the first quarter of 2026. The company typically releases earnings in the morning before market open, consistent with its historical reporting pattern. This upcoming release will provide investors with Q1 2026 financial results, including earnings per share and revenue figures for the quarter ending March 31, 2026.
Ambev (ABEV) Next Earnings Date
Ambev S.A. (ABEV) has not officially confirmed its next earnings date, but estimates point to February 12, 2026, aligning with the company's historical pattern for Q4 2025 results. This release will cover the quarter ending December 2025, typically reported before market open. Investors should monitor official announcements for any updates, as dates can shift slightly.
Colgate-Palmolive (CL) Next Earnings Date
Colgate-Palmolive's next earnings report is scheduled for April 23-24, 2026, covering the first quarter of 2026. The company typically releases earnings in the morning before market open, consistent with its historical reporting pattern. This upcoming release will provide investors with Q1 2026 financial results, including earnings per share and revenue figures for the quarter ending March 31, 2026.
Ambev (ABEV) Next Earnings Date
Ambev S.A. (ABEV) has not officially confirmed its next earnings date, but estimates point to February 12, 2026, aligning with the company's historical pattern for Q4 2025 results. This release will cover the quarter ending December 2025, typically reported before market open. Investors should monitor official announcements for any updates, as dates can shift slightly.
Which Baskets Do They Appear In?
Familiar brands might ease stock market anxiety?
Investing in familiar global brands can make the stock market feel more accessible and understandable for many Brazilians. This basket offers exposure to the US and EU-listed parent companies behind the everyday consumer products found in homes across Brazil.
Published: October 13, 2025
Explore BasketWhich Baskets Do They Appear In?
Familiar brands might ease stock market anxiety?
Investing in familiar global brands can make the stock market feel more accessible and understandable for many Brazilians. This basket offers exposure to the US and EU-listed parent companies behind the everyday consumer products found in homes across Brazil.
Published: October 13, 2025
Explore BasketBuy CL or ABEV in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Comparisons
Colgate-Palmolive vs Kroger
Colgate-Palmolive vs Kroger stock comparison
Colgate-Palmolive vs Diageo
Colgate-Palmolive vs Diageo: a quick comparison
Colgate-Palmolive vs Kimberly-Clark
Colgate-Palmolive vs Kimberly-Clark